Ce document informatif met en évidence l'impact du programme d'action communautaire en matière de réduction des risques sur la vie des personnes qui usent de drogues injectables et les membres de leur famille. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.
Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.
Community Action on Harm Reduction (CAHR) is an ambitious programme implemented between 2011 and 2015 with the objective of expanding coverage of HIV prevention, treatment and care, sexual and reproductive health and other services to more than 230,000 people who inject drugs (PWID), their partners and children in five countries – China, India, Indonesia, Kenya and Malaysia – and, since 2015, with the addition of Myanmar, through funding from the Social Department/Health and AIDS Division of the Ministry of Foreign Affairs of the Government of The Netherlands. Due to specific higher-risk behaviours, PWID are at increased risk of HIV irrespective of the epidemic type or local context; they often have legal and social issues related to their behaviours that increase their vulnerability to HIV.
The programme is implemented through a consortium of Alliance Linking Organisations (LOs): AIDS Care China, India HIV/AIDS Alliance (Alliance India), Rumah Cemara in Indonesia, the Kenya AIDS NGO Consortium (KANCO), the Malaysian AIDS Council (MAC), and Alliance Myanmar, in collaboration with four international policy partners: the International HIV/AIDS Alliance, Harm Reduction International (HRI), the International Drug Policy Consortium (IDPC) and the International Network of People who Use Drugs (INPUD); several other agencies also provide specialised technical assistance in various areas.
This briefing document highlights the impact on the lives of PWID and their family members of the CAHR programme as well as the continued support needed by PWID to fully realise their right to quality health services that are evidence-based and free from stigma and discrimination.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.